Levodropropizine: Clinical Trials

4 trials of Levodropropizine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Phase 3, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Phase 11Completed 1
Phase 21Unknown 1
Phase 41Completed 1

Follow Levodropropizine: new trials by email Literature Review of Levodropropizine trials Research Report on Levodropropizine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
Codeine, Levodropropizine, Ivy Leaves Cough Liquid - Upper Resp Tract Infection
Phase 4CompletedPontificia Universidad Catolica de Chile1962025-05-132025-12-03
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases
Furosemide 40 mg, Levodropropizine, Placebo - saline - Dyspnea
Phase 2 / Phase 3UnknownUniversity Hospital Hradec Kralove1022024-02-272024-04-16
Clinical Trial of Efficacy and Safety of Levopront® 30 mg/5 ml in Patients With Dry Cough
Levopront® syrup 30 mg/5 ml, Libexin® - Cough
Phase 3CompletedDompé Farmaceutici S.p.A1842016-11-092024-04-16
A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
Ambroxol and Levodropropizine, Ambroxol, Levodropropizine - Healthy
Phase 1CompletedHanmi Pharmaceutical Company Limited212012-02-012012-07-19

Conditions studied

Cough (2)  ·  Dyspnea (1)  ·  Respiratory Tract Infections (1)

Sponsors

Dompé Farmaceutici S.p.A (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  University Hospital Hradec Kralove (1)

Countries

Chile (1)  ·  Czechia (1)  ·  Russia (1)  ·  South Korea (1)

Top investigators

Federico Saibene, MD (1)  ·  Vladimir Koblizek, PhD (1)  ·  Wooseong Huh, MD (1)

NIH funding

2018 (1)